COVID-19 vaccination and breakthrough infections in patients with cancer.

AL, Schmidt; C, Labaki; CY, Hsu; Z, Bakouny; N, Balanchivadze; SA, Berg; S, Blau; A, Daher; Zarif T, El; CR, Friese; EA, Griffiths; JE, Hawley; B, Hayes-Lattin; V, Karivedu; T, Latif; BH, Mavromatis; RR, McKay; G, Nagaraj; RH, Nguyen; OA, Panagiotou; AJ, Portuguese; M, Puc; Dutra M, Santos; BA, Schroeder; A, Thakkar; EM, Wulff-Burchfield; S, Mishra; D, Farmakiotis; Y, Shyr; JL, Warner; TK, Choueiri

doi:10.1016/j.annonc.2021.12.006

Public

COVID-19 vaccination and breakthrough infections in patients with cancer.

Shared by NobleBlocks on Dec 24, 2021 • 12:00 AM UTC

Authors:

Schmidt AL

Labaki C

Hsu CY

Abstract

Background Vaccination is an important preventive health measure to protect against symptomatic and severe COVID-19. Impaired immunity secondary to an underlying malignancy or recent receipt of antineoplastic systemic therapies can result in less robust antibody titers following vaccination and poss...

Subject

Cancer

Neoplasm

Vaccination

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!